news_reference/
26 pages · Updated July 26, 2026
Pages
- HotSpot Therapeutics secures $100M to advance allosteric platform - HotSpot Therapeutics
- Cancer-Targeting Biotech Startup HotSpot Therapeutics Raises $100M - HotSpot Therapeutics
- AbbVie offers up to $335M for connection with HotSpot’s preclinical small-molecule program - HotSpot Therapeutics
- SR One fuels HotSpot's $65M B round to fund allosteric R&D - HotSpot Therapeutics
- HotSpot Therapeutics Adds $65M to Steer Allosteric Medicines to the Clinic - HotSpot Therapeutics
- Boston's HotSpot Therapeutics Eyes The Clinic Following $65 Million Series B - HotSpot Therapeutics
- Atlas-backed startup raises $100M for protein 'hotspots' - HotSpot Therapeutics
- HotSpot heads for clinic with $65M series B round to develop allosteric modulators - HotSpot Therapeutics
- AbbVie puts up $40M to license a treatment from HotSpot Therapeutics - HotSpot Therapeutics
- Boston Neighbors Net $256 Million for Treg and Allosteric Therapies - HotSpot Therapeutics
- HotSpot announces $65M Series B, as Nimbus pioneers look to keep up in a crowding field - HotSpot Therapeutics
- HotSpot Therapeutics snags $100M series C to bring allosteric meds into the clinic - HotSpot Therapeutics
- HotSpot gets hotter with $100M raise to push toward clinic - HotSpot Therapeutics
- Hotspot’s $65M series B to propel it into the clinic - HotSpot Therapeutics
- HotSpot acquires DNA-encoded library firm Macroceutics - HotSpot Therapeutics
- Getting higher-quality hits out of DNA-encoded libraries - HotSpot Therapeutics
- HotSpot Acquires Macroceutics for focused allosteric library - HotSpot Therapeutics
- Allostery: Realizing The Promise - HotSpot Therapeutics
- HotSpot Therapeutics debuts with $45 million to pursue allosteric inhibitors - HotSpot Therapeutics
- Drug hunters explore allostery’s advantages - HotSpot Therapeutics
- Float like a butterfly: agility in biotech - HotSpot Therapeutics
- Moving beyond the active site: why allostery is newly in fashion - HotSpot Therapeutics
- Atlas, Sofinnova Bet $45M on 'HotSpots' - HotSpot Therapeutics
- HotSpot debuts with $45m to find, drug natural allosteric sites - HotSpot Therapeutics
- With $45M, HotSpot Takes Drug Research to New Biological Real Estate - HotSpot Therapeutics
- Hotspot Therapeutics Turns Up The Heat On Natural Allostery - HotSpot Therapeutics